Breast Cancer

Opting for hormonal or nonhormonal fertility preservation is unlikely to affect a woman’s risk for death or disease recurrence after receiving a diagnosis of breast cancer.

I never thought I’d admit experiencing fear of cancer recurrence, but at a recent medical appointment I realized that I struggle with this fear daily.

Black women were more likely to benefit from neoadjuvant endocrine therapy for early-stage breast cancer, however, their outcomes were inferior to White women when it came to late-stage disease, recent research showed.

Extra years with my family meant missing out on a free trip granted to patients with cancer who have children under the age of 18 — and I’m OK with that.

Although rates of pathologic complete response to neoadjuvant — also known as presurgical — chemotherapy were lower in men than women with breast cancer, this may highlight an area of further research of treating this cancer in men.

As “Pinktober” approaches, I’m spreading the message that breasts are not needed to live a full life after breast cancer surgery.

As National Previvor Day approaches, I’m getting back on my soapbox to discuss genetic testing and family histories of cancer. After all, these discussions could save lives.

Compared to physician’s choice of treatment, Trodelvy improved survival and quality of life in pretreated patients with HR positive/HER2 negative metastatic breast cancer.

Adding the novel drug oleclumab to Imfinzi and chemotherapy for the frontline treatment of advanced triple-negative breast cancer did not improve clinical outcomes, according to recent study findings.

When my daughter first started cancer treatment, she was brave, but after she understood how difficult it was, she was courageous in continuing.

The Food and Drug Administration issued a statement about the incidence of new cases of rare cancers that have occurred in the scar tissue around breast implants.

When celebrities are diagnosed with cancer, they wield great power to bring awareness to the disease but being in the public eye must be extremely challenging, especially when facing a personal health crisis.

I’ve channeled my cancer-related anger into advocacy, and made a “living list” of things I want to accomplish.

I recently came across a shoebox full of cards sent to me after I was diagnosed with cancer. The love expressed by others was uplifting to me.

Trodelvy bested chemotherapy for progression-free survival in patients with HR-positive, HER2-negative metastatic breast cancer.

I was paralyzed with fear before starting chemotherapy, but one oncology nurse helped me feel at ease.

From “Good Morning America” host Robin Roberts stepping away from the show after her partner finished breast cancer radiation to a former Tampa Bay Buccaneer dying of leukemia, here is what’s happening in the cancer space this week.

Patients with breast cancer who received post-mastectomy breast reconstruction had similar recurrence rates regardless of the timing of their reconstructive surgery, according to recent study findings.

I’m giving cancer’s “battle language” an update and focusing my survivorship plan on emotional wellbeing and honesty.

From the death of a football Hall of Famer and a golf champion to actress and former Nickelodeon star Jennette McCurdy discussing her mother’s breast cancer in her memoir, “I’m Glad My Mom Died,” here’s what’s happening in the cancer space this week.

Here's a step-by-step guide on how I drew the superhero that I wish existed to fight my wife's cancer.

Among the many lessons I’ve learned since my diagnosis with cancer, there’s one in particular that I refer to daily. It’s a lesson learned from wearing a pair of odd-looking shoes.

My doctor once told me that if you're old enough to fight for your country, then you're old enough to get breast cancer.

As I reflect on four years of “warriorhood” since being diagnosed with cancer, I wrote a letter to my younger self and others who are just receiving diagnosis.

My choice to not undergo chemotherapy for breast cancer was not an easy one, but looking back, I don’t regret it.

A patient with metastatic breast cancer recalls the emotional experience of being among the thousands of attendees who gave a standing ovation in an auditorium in Chicago when the results of the phase 3 DESTINY-Breast04 trial — which recently led to the FDA approval of Enhertu in HER2-low disease — were presented at the 2022 ASCO Annual Meeting.

Prior to my breast cancer diagnosis, my only goal in life was for my son to turn 16 so he could drive me to and from the local bars. Now I can’t help but think that my cancer was meant for me to change my life.

The use of Trodelvy was associated with a significant improvement in survival when compared with physician’s choice of chemotherapy in patients with HR-positive, HER2-negative metastatic breast cancer, according to recently announced study findings.

A phase 2 trial will analyze the novel drug ART4215 with Talzenna, a PARP inhibitor, for patients with BRCA-deficient breast cancer.

A psychiatrist advises patients with cancer to speak up about their mental health concerns during cancer treatment, as there are tools that can guide best next steps.